Advertisement

Topics

GL Capital-led consortium to buy SciClone Pharmaceuticals

06:12 EDT 9 Jun 2017 | Pharmaceutical Business Review

A consortium featuring entities affiliated with GL Capital Management GP, Bank of China Group Investment (BOCGI), CDH Investments, Ascendent Capital Partners and Boying will acquire all the outstanding shares of SciClone Pharmaceuticals for $11.18 per share in cash.

Original Article: GL Capital-led consortium to buy SciClone Pharmaceuticals

NEXT ARTICLE

More From BioPortfolio on "GL Capital-led consortium to buy SciClone Pharmaceuticals"

Quick Search
Advertisement